Home
NICE Guidance
Published Guidance

Docetaxel for the adjuvant treatment of early node-positive breast cancer

Technology appraisal guidance [TA109] Published: 26 September 2006

Guidance

This guideline has been updated and replaced by NICE guideline NG101.